Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Eugene Lo is a pioneering hepatobiliary and pancreatic surgeon whose research focuses on advancing minimally invasive surgical techniques for liver and pancreatic cancers. His major contributions lie in demonstrating the safety and efficacy of robotic hepatectomy and pancreatectomy, challenging the traditional dominance of open surgery. In a landmark 2020 propensity score-matched study (39 citations), he showed that robotic hemihepatectomy offers comparable oncologic outcomes with reduced blood loss and shorter hospital stays compared to open procedures. His 2023 analysis of 224 hepatocellular carcinoma patients (7 citations) further validated the benefits of minimally invasive liver resection, establishing critical benchmarks for patient selection. Dr. Lo has also advanced organ-preserving strategies, as evidenced by his 2021 comparative study on robotic distal pancreatectomy (3 citations), which explored splenic vessel and spleen preservation to reduce postoperative morbidity. Through rigorous comparative effectiveness research, Dr. Lo is shaping the future of surgical oncology, providing evidence that robotic approaches can achieve the same radical resections with less trauma—a paradigm shift that improves recovery and quality of life for patients facing complex hepatobiliary malignancies.